Plastic Surgery Practice
  • Client Objectives
    • Aesthetics
    • Dermatology
    • Rejuvenation
  • Practice Management
    • Marketing
    • Office Management
    • Technology
  • Treatment Solutions
    • Innovations
    • Products
    • Pharmaceuticals
  • Resources
    • Podcasts
    • Videos
    • Webinars
    • White Papers

Select Page

Tag: FDA clearance

All

Popular
FDA Clears Expanded Indications for Swift Microwave Wart Device

FDA Clears Expanded Indications for Swift Microwave Wart Device

New data show the Swift system reduces blistering, discomfort, and recovery time while maintaining strong clinical outcomes for common and plantar warts.

  • FDA Clears Suction-Based Device for Removal of Ruptured Breast Implants

  • FDA Accepts Revance Resubmission for Frown Line Treatment

  • FDA Approves Revance Daxxify for Frown Lines

  • FDA Clears Sofwave to Improve the Appearance of Cellulite

  • FDA Clears All-in-One Body Contouring System

  • FDA Clears Sofwave Standalone EMS Device for Muscle Toning

  • FDA Clears Dermalogica PRO Pen Microneedling Device

  • Apyx Medical Submits FDA 510(k) to Add Power Liposuction to Body Contouring System

All

Latest
Wingderm Receives FDA Clearance for Lasermach Across Three Wavelengths

Wingderm Receives FDA Clearance for Lasermach Across Three Wavelengths

Expanded clearance allows the system to support hair removal and vascular lesion treatment using multiple wavelength configurations.

All

Latest
Skin Barrier Changes Precede Visible Signs of Flap Necrosis, Study Finds

Skin Barrier Changes Precede Visible Signs of Flap Necrosis, Study Finds

Monitoring transepidermal water loss and hydration identified high-risk skin flaps within the first three postoperative days, potentially enabling earlier intervention.

  • Beyond the Pitch: Navigating the Complexities of Sports-Related Nasal Trauma

    Beyond the Pitch: Navigating the Complexities of Sports-Related Nasal Trauma

  • Allergan Wins First Approval for Short-Acting Neurotoxin in Canada

    Allergan Wins First Approval for Short-Acting Neurotoxin in Canada

  • MediaPSC Debuts Social Media Solution Designed for Healthcare Practices

    MediaPSC Debuts Social Media Solution Designed for Healthcare Practices

Sorry, No Posts Found

Plastic Surgery Practice

7300 W 110th St – Floor 7
Overland Park, KS 66210
(913) 955-2600

Our Parent Company

MEDQOR LLC

About MEDQOR

MEDQOR Data Platform

Press Releases

Key Resources

Podcasts

Webinars

White Papers

Videos

Helpful Links

Media Solutions Kit

Subscribe Now

Contact Us

  • Follow
  • Follow
  • Follow
  • Follow
  • Follow

Copyright

Privacy Policy

Terms of Service

© 2024 MEDQOR LLC. All Rights Reserved